Selected EMA news, June 2025

New medicines recommended for approval

  • Aucatzyl (obecabtagene autoleucel) – orphan medicine – conditional approval
    Treatment of lymphoblastic leukaemia (blood cancer)
  • Blenrep (belantamab mafodotin)
    Treatment of multiple myeloma (blood cancer)

Supply shortages

  • NovoSeven (eptacog alfa) (eptacog alfa (activated))
    Treatment of bleeding episodes and prevention of bleeding after surgical procedures
Share